Company intelligence / Profile preview

Agathon

Seoul, Seoul Special City, South Koreaagathon.ch ↗

Ownership: Private
Development stage: Other

Overview

AGATHON BIO specializes in global innovative new drug development support, scale-up research & process development for APIs (Active Pharmaceutical Ingredients), non-clinical/clinical API production, small-scale API production, and import & distribution of APIs. There is no public information about proprietary clinical programs or pipeline drugs. The company's main business model appears to be contract manufacturing and R&D services.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Agathon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agathon.

Explore the full profile